Jean-Pierre Van geertruyden
3 clinical trials · Sponsor
◉ Watch Jean-Pierre Van geertruyden
| Record | Firm | Date |
|---|---|---|
| Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC (NCT06844500) | Jean-Pierre Van geertruyden | 2025-06-23 |
| Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC (NCT06844487) | Jean-Pierre Van geertruyden | 2025-05-29 |
| Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix (NCT02346227) | Jean-Pierre Van geertruyden | 2015-01-01 |
Track Jean-Pierre Van geertruyden automatically
Every clearance here is in the API, with alerts when new ones post.